
%0 Journal Article
%A Wong, YF 
%A Loong, EP 
%A Mao, KR 
%A Tam, PP 
%A Panesar, NS 
%A Neale, E 
%A Chang, AM 
%T Salivary oestradiol and progesterone after in vitro fertilization and embryo transfer using different luteal support regimens
%J Reproduction, Fertility and Development
%D 1990/08/01
%V 2
%N 4
%P 351-358
%K 
%R https://doi.org/10.1071/RD9900351
%U https://www.publish.csiro.au/paper/RD9900351 
%X Salivary oestradiol (E2) and progesterone (P) levels have been shown to reflect the biologically active fractions in the serum. The luteal-phase status of stimulated cycles was investigated after in vitro fertilization and embryo transfer (IVF-ET). Thirty patients were randomly allocated to one of three luteal therapy groups: group A had no support, group B had intramuscular P and group C had intramuscular P and human chorionic gonadotrophin (hCG). One pregnancy was achieved in group A, two in group B and three in group C. Significant correlations between salivary and serum levels of E2 and of P in matched samples during luteal phase were found. Salivary E2 levels from luteal day 8 through day 14 and P levels from day 3 through day 14 were significantly higher in the pregnant than in the nonpregnant cycles. Among the nonpregnant cycles, salivary E2 and P levels were significantly higher in group C than in group A or B. These findings suggest that, in stimulated cycles for IVF-ET, determination of salivary E2 and P levels may be used as reliable alternatives to serum concentrations for assessing the luteal phase. Also, the additional hCG has an enhanced luteotrophic effect, as reflected by the higher salivary E2 and P levels, which may lead to a better pregnancy rate. 
